Description

Dosage
10mg

Total amount
1 vial + 1 ampoule of water

Component
Retatrutide

10MG VIAL WITH 2ML WATER AMPOULE

Pharmaqo proudly introduces Retatrutide 10mg a cutting-edge, research-grade peptide at the forefront of obesity and metabolic disorder studies. Engineered as a triple-receptor agonist, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, delivering a synergistic effect on metabolic regulation, appetite suppression, insulin activity, and fat utilization.

This unique mechanism has positioned Retatrutide as a next-generation candidate in the fight against obesity, offering greater potency and multifaceted benefits compared to single-pathway peptides.

Mechanism of Action

GLP-1 Activation: Suppresses appetite, delays gastric emptying, and enhances insulin secretion.

GIP Activation: Improves insulin response and glucose homeostasis.

Glucagon Receptor Activation: Stimulates energy expenditure and mobilization of stored fat.

Together, these actions result in comprehensive metabolic improvements?ideal for clinical studies focusing on weight loss, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD).